Table 1 Descriptive characteristics of the study cohort stratified by event status (N = 382)
From: Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer
Variable | Overall | Non-BCR | BCRa |
|---|---|---|---|
N (%) | 382 | 310 (81.2) | 72 (18.8) |
Age at RP (years) | |||
 Mean (SD) | 58.2 (8.3) | 57.9 (8.3) | 59.4 (8.3) |
Race—N (%) | |||
 CA & Other | 314 (82.2) | 258 (82.2) | 56 (17.8) |
 AA | 68 (17.8) | 52 (76.5) | 16 (13.5) |
Pathological T stage—N (%) | |||
 pT2 | 259 (72.8) | 232 (89.6) | 27 (10.4) |
 pT3–4 | 97 (27.2) | 62 (63.9) | 35 (36.1) |
Gleason sum—N (%) | |||
 3 + 3 | 196 (54.3) | 178 (90.8) | 18 (9.2) |
 3 + 4 | 105 (29.1) | 91 (86.7) | 14 (13.3) |
 4 + 3/8 − 10 | 60 (16.6) | 31 (51.7) | 29 (48.3) |
Surgical margin—N (%) | |||
 Negative | 311 (81.8) | 263 (84.5) | 48 (15.4) |
 Positive | 69 (18.2) | 46 (66.7) | 23 (33.3) |
Follow up time (years) | |||
 Median (range) | 6.9 (0.2–18.6) | 6.6 (0.2–18.6) | 8.2 (1.5–17.8) |